Hannu Alho

Medicine · Health Sciences

55h-index10.3kcitations322works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Substance Abuse Treatment and Outcomes(51), Opioid Use Disorder Treatment(43), Gambling Behavior and Treatments(42), Alcohol Consumption and Health Effects(40), Neuroscience and Neuropharmacology Research(37)

Publications322 total

Factors influencing treatment outcomes in a randomised clinical trial for gambling disorder: a secondary analysis
European Addiction Research·2026Open Access
Comparison of Extended-Release Buprenorphine Doses for Treating High-Risk Opioid Use
JAMA Network Open·2025· 1 citedOpen Access
Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine
JAMA Network Open·2025· 3 citedOpen Access
557 A Randomized Study Comparing Rapid Versus Standard Induction to Buprenorphine Extended-Release Injection
Annals of Emergency Medicine·2025Open Access
Treatment of Pathological Gambling with Naltrexone Pharmacotherapy and Brief Intervention: A Pilot Study
Psychopharmacology Bulletin·2025· 9 cited
A RANDOMIZED OPEN-LABEL STUDY COMPARING RAPID AND STANDARD INDUCTIONS TO INJECTABLE BUPRENORPHINE EXTENDED-RELEASE (BUP-XR) TREATMENT
Drug and Alcohol Dependence·2025
CT-optimal touch modulates alcohol-cue-elicited heart rate variability in alcohol use disorder patients during early abstinence: A randomized controlled study
Alcohol·2024· 1 citedOpen Access
Factors influencing treatment outcomes in a randomised clinical trial for gambling disorder
2024Open Access
Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypes
European Journal of Internal Medicine·2024· 6 citedOpen Access
Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment.
European Journal of Internal Medicine·2024· 5 citedOpen Access
A Phase 3 Randomized Precision Medicine Clinical Trial Using Low-Dose Ondansetron (a 5-HT3 Antagonist) to Treat Alcohol Use Disorder
Research Square (Research Square)·2023Open Access
A Prospective Precision Medicine Phase 3 Clinical Trial of Low-dose Ondansetron (a 5-ht3 Antagonist) to Treat Heavy and Very Heavy Drinkers With Alcohol Use Disorder
Research Square (Research Square)·2023Open Access
Intranasal as needed naloxone in the treatment of gambling disorder: A randomised controlled trial
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)·2022
A Prospective Pharmacogenetic Phase 3 Clinical Trial of Low-Dose Ondansetron (A 5-HT3 Antagonist) to Treat Heavy and Very Heavy Drinkers With Alcohol Use Disorder
Research Square (Research Square)·2022· 1 citedOpen Access
Intranasal as needed naloxone in the treatment of gambling disorder: A randomised controlled trial
Addictive Behaviors·2021· 10 citedOpen Access
Alcohol dependence treatment in the EU: A literature search and expert consultation about the availability and use of guidelines in all EU countries plus Iceland, Norway, and Switzerland
2021· 1 citedOpen Access
Alcohol dependence treatment in the EU: A literature search and expert consultation about the availability and use of guidelines in all EU countries plus Iceland, Norway, and Switzerland
2021Open Access
Amfetamiinien ja opioidien ongelmakäytön yleisyys Suomessa vuonna 2017
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)·2020· 2 citedOpen Access
Opioid-related deaths in Europe: Strategies for a comprehensive approach to address a major public health concern
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)·2020· 1 cited
Recommandations pour le traitement du trouble de l’usage des opioïdes par la buprénorphine et la méthadone. Consensus européen
Alcoologie et Addictologie·2019
page 1 of 17Next →

Frequent Co-authors

E. Costa(8), Alessandro Guidotti(6), Carlo Ferrarese(4), Ferdinando Nicoletti(3), Janne Leinonen(3), Jouko Lönnqvist(3), Juho Joutsa(3), Jarkko Johansson(3), Eveliina Arponen(3), Valerie Voon(3), Valtteri Kaasinen(3), Mauri Aalto(3), Jukka Halme(3), Kaija Seppä(3), Kimmo Lönnrot(3), Juha Kononen(3), Patrizia Bovolin(3), Icro Maremmani(3), Kari Poikolainen(3), Flora M. Vaccarino(3)